Home > Healthcare > Pharmaceuticals > Finished Drug Form > Sulphonamides Market

Sulphonamides Market Size

Report ID: GMI9708
Published Date: May 2024
Report Format: PDF

Download Free Sample

Sulphonamides Market Size

Sulphonamides Market was valued at USD 122.4 million in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032, driven by the increasing prevalence of infectious diseases globally. Furthermore, the increasing awareness among healthcare providers and patients about the effectiveness of sulphonamides is contributing to their higher prescription rates, thereby further expanding the market growth.

Sulphonamides Market

To get key market trends

Download Free Sample

Sulphonamide treatment involves the use of medications from the sulphonamide group, which are synthetic antimicrobial agents. These drugs inhibit the growth and multiplication of bacteria by acting as competitive inhibitors of the enzyme dihydropteroate synthase involved in folate synthesis. Sulphonamides are bacteriostatic, meaning they inhibit bacterial growth without killing the bacteria. They are commonly used to treat bacterial infections, UTIs, and other conditions.

Sulphonamides Market Report Attributes
Report Attribute	Details
Base Year:	2023
Sulphonamides Market Size in 2023:	USD 122.4 Million
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	4.8%
2032 Value Projection:	USD 184.4 Million
Historical Data for:	2021 – 2023
No. of Pages:	242
Tables, Charts & Figures:	259
Segments covered:	Route of Administration, Application, Medication Type, Distribution Channel, and Region
Growth Drivers:	Rising incidence of bacterial infection worldwide Growing R&D activities in pharmaceutical companies Growing demand for combination antibiotic therapies Supportive government initiatives
Pitfalls & Challenges:	Side effects associated with the use of sulfa drugs Availability of alternative antibiotics

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of sulphonamides was reached USD 122.4 million in 2023 and will grow at 4.8% CAGR from 2024 to 2032, driven by the increasing prevalence of infectious diseases globally.

The oral administration mode segment of the sulphonamides market recorded USD 66.2 million in 2023 and will reach USD 98.6 million by 2032, as it offers convenient administration, facilitating patient compliance and ensuring timely treatment initiation.

U.S. sulphonamides market size accounted for USD 48 million in 2023 and is anticipated to show significant growth, due to high prevalence and incidence of infectious diseases.

Aurobindo Pharma, Bausch & Lomb Incorporated, Cadila Pharmaceuticals Ltd, Cipla Ltd, Dr. Reddy’s Laboratories, F. Hoffmann-La Roche Ltd, GSK PLC, Glenmark Pharma Ltd, and Lexine Technochem Pvt. Ltd. among others.